Skip to main content
OpenTrials
Completed

NCT Number: NCT06086756

Virtual Reality Intervention for Speech Anxiety

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for Anxiety and Related Disorders

Boston, Massachusetts, 02215, United States

About this study

The goal of this clinical trial is to compare outcomes of VR exposure therapy for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to determine whether mood state prior to engaging in a brief VR exposure therapy session for public speaking anxiety impacts treatment outcomes.

The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later.

Researchers will compare participants given a positive mood induction to participants given a negative mood induction to see if public speaking anxiety outcomes differ.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-report of 18 years of age or older
  • Current student at Boston University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet).
  • For Phase 2: speech anxiety scale score of ≥ 14 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Exclusion criteria

  • Previous participation (i.e., no participant may take the survey more than once).

Treatment and study plan

Exposure intervention plus positive mood induction

Behavioral

Positive mood induction followed by a brief VR exposure session for public speaking anxiety.

Exposure intervention plus negative mood induction

Behavioral

Negative mood induction followed by a brief VR exposure session for public speaking anxiety.

Primary outcomes

  1. Public Speaking Anxiety

    Time frame: Comparison of pre-exposure scores to scores from post-treatment, approximately 2 week post-screen

    Assessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Secondary outcomes

  1. Valence

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

    Self-report measure of how participant feels about having to give a speech

  2. Social Phobia

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

    Assessed using the social phobia inventory (SPIN)

  3. Public Speaking Anxiety

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

    Assessed using the PRCA-PS

Sponsors and collaborators

Lead sponsor

Boston University Charles River Campus

Other

Registry information

Official study title

The Influence of Mood on Response to Virtual Reality-Based Exposure for Public Speaking Anxiety

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 17, 2023
Registry last updated
Dec 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.